- Home
- ATHA vs CTRM Comparison
ATHA vs CTRM Comparison
Compare ATHA & CTRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATHA | CTRM |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | Cyprus |
| Employees | 26 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0M | 21.1M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATHA | CTRM |
|---|---|---|
| Price | $6.91 | $2.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 86.7K |
| Earning Date | 02-26-2026 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $75,412,579.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.20 | $1.84 |
| 52 Week High | $8.36 | $2.96 |
Technical Indicators
Market Signals| Indicator | ATHA | CTRM |
|---|---|---|
| Relative Strength Index (RSI) | 62.50 | 49.65 |
| Support Level | $6.41 | $2.02 |
| Resistance Level | $7.64 | $2.46 |
| Average True Range (ATR) | 0.69 | 0.11 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 68.86 | 32.06 |
Price Performance
Historical ComparisonAbout ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.